World / Cancer
Study Reveals Genetic Links To Common Form Of Leukaemia
01.09.2008 06:27
medicalnewstoday.com
For the first time researchers have proved that there is a genetic susceptibility to developing chronic lymphocytic leukaemia (CLL), the most common form of leukaemia in the Western world. Whilst anecdotal evidence has suggested that inherited factors play a role in the development of CLL, scientists have until now been unable to prove a genetic basis.
World
Cancer
ERBITUX(R) Phase 3 BMS-099 Lung Cancer Study Secondary Endpoint Update: Overall Survival Results Announced
01.09.2008 06:27
medicalnewstoday.com
ImClone Systems Incorporated (NASDAQ: IMCL) announced overall survival results from BMS CA225-099 (BMS-099), an open-label Phase 3 study of ERBITUX® (cetuximab) in combination with a taxane and carboplatin in the first-line treatment of all histological subtypes of advanced non-small cell lung cancer (NSCLC).
World
Cancer
Cytokinetics Announces Clinical Trials Data Relating To Ispinesib To Be Presented At The 2008 ASCO Breast Cancer Symposium
01.09.2008 04:24
medicalnewstoday.com
Cytokinetics, Incorporated (NASDAQ: CYTK) announced that data from an ongoing Phase I/II clinical trial of ispinesib are scheduled to be presented as a poster presentation at the 2008 American Society of Clinical Oncology (ASCO) Breast Cancer Symposium, to be held September 5-7, 2008 at the Hilton Washington in Washington, DC.
World
Cancer
Growth Factor Predicts Poor Outcome In Breast Cancer
01.09.2008 04:24
medicalnewstoday.com
The response to insulin-like growth factor 1 (IGF-I) in breast cancer cells predicts an aggressive tumor that is less likely to respond to treatment, said researchers at Baylor College of Medicine in a report that appears in the current issue of the Journal of Clinical Oncology. The finding gives impetus to the movement to tailor cancer treatments to attributes of the various tumors. "These findings come at a critical time," said Dr.
World
Cancer
English